Domellöf Magnus, Dewey Kathryn G, Lönnerdal Bo, Cohen Roberta J, Hernell Olle
Department of Clinical Sciences, Pediatrics, Umeå University, Sweden.
J Nutr. 2002 Dec;132(12):3680-6. doi: 10.1093/jn/132.12.3680.
Diagnostic criteria for iron deficiency (ID) and iron deficiency anemia (IDA) in infants are poorly defined. Our aim was to establish appropriate cut-off values for hemoglobin (Hb), plasma ferritin, erythrocyte mean cell volume (MCV), zinc protoporphyrin (ZPP) and soluble transferrin receptors (TfR) in infancy. Exclusively breast-fed infants (n = 263) in Honduras and Sweden were randomly assigned to receive iron supplementation or placebo, and blood samples were obtained at 4, 6 and 9 mo of age. Reference ranges were determined using three different approaches for defining iron-replete infants. The usefulness of several variables for predicting the Hb response to iron was evaluated. We found the following 2 SD cut-off values in iron-replete infants: Hb <105 g/L at 4-6 mo and <100 g/L at 9 mo; ZPP >75 micro mol/mol heme at 4-6 mo and >90 micro mol/mol heme at 9 mo; ferritin <20 micro g/L at 4 mo, <9 micro g/L at 6 mo and <5 micro g/L at 9 mo; and TfR >11 mg/L at 4-9 mo. The Hb response to iron was not a useful definition of IDA at 4 mo of age. Hb, MCV and ZPP at 6 mo as well as growth variables predicted the Hb response at 6-9 mo, but ferritin and TfR at 6 mo did not. We conclude that there is need for a reevaluation of the definitions of ID and IDA in infants.
婴儿缺铁(ID)和缺铁性贫血(IDA)的诊断标准尚不明确。我们的目的是确定婴儿期血红蛋白(Hb)、血浆铁蛋白、红细胞平均体积(MCV)、锌原卟啉(ZPP)和可溶性转铁蛋白受体(TfR)的合适临界值。在洪都拉斯和瑞典,将263名纯母乳喂养的婴儿随机分为两组,分别接受铁补充剂或安慰剂,并在4、6和9月龄时采集血样。采用三种不同方法定义铁充足婴儿,从而确定参考范围。评估了几个变量对预测铁治疗后Hb反应的有效性。我们发现铁充足婴儿的以下2个标准差临界值:4 - 6月龄时Hb <105 g/L,9月龄时<100 g/L;4 - 6月龄时ZPP >75 μmol/mol血红素,9月龄时>90 μmol/mol血红素;4月龄时铁蛋白<20 μg/L,6月龄时<9 μg/L,9月龄时<5 μg/L;4 - 9月龄时TfR >11 mg/L。4月龄时铁治疗后的Hb反应并非IDA的有效定义。6月龄时的Hb、MCV和ZPP以及生长变量可预测6 - 9月龄时的Hb反应,但6月龄时的铁蛋白和TfR则不能。我们得出结论,有必要重新评估婴儿ID和IDA的定义。